Sysmex Co. (OTCMKTS:SSMXY) Short Interest Update

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a significant decrease in short interest in February. As of February 28th, there was short interest totalling 3,000 shares, a decrease of 25.0% from the February 13th total of 4,000 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 112,900 shares, the short-interest ratio is presently 0.0 days.

Sysmex Stock Performance

Shares of SSMXY traded down $0.07 during mid-day trading on Thursday, hitting $19.17. 34,494 shares of the company's stock were exchanged, compared to its average volume of 68,820. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. Sysmex has a 52 week low of $14.38 and a 52 week high of $28.32. The stock's 50-day simple moving average is $18.56 and its 200-day simple moving average is $19.11. The firm has a market cap of $12.07 billion, a price-to-earnings ratio of 37.38 and a beta of 0.88.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.17 EPS for the quarter. On average, equities research analysts expect that Sysmex will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.